MENU
OMER
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Omeros (OMER) Ownership - Who owns Omeros?

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
201 Elliott Avenue West
Phone
+1 206 676-5000
Employees
175
Web
https://www.omeros.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
747.28M
P/E Ratio
9.06
Total Cash
135.32M
Projected Growth
N/A
Total Debt
148.85M
Revenue
9.89M
Risk (Beta)
3.91
Dividend Yield
N/A
Total Cash/Share
1.87
Total Debt/Equity
618.04
Revenue/Share
0.14 USD as % of share price
View a ticker or compare two or three
OMER
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
201 Elliott Avenue West
Phone
+1 206 676-5000
Employees
175
Web
https://www.omeros.com